Chloroquine Drug for COVID-19 Market
Chloroquine Drug for COVID-19 Market Scope:
Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Chloroquine Drug for COVID-19 Market Size and Growth
Chloroquine, initially utilized for malaria, gained attention in the COVID-19 landscape but faced limited clinical efficacy. The global market saw significant fluctuations, with size estimates peaking at approximately $500 million during early pandemic phases. Current trends indicate a shift towards more effective therapies, diminishing Chloroquine's relevance in COVID-19 treatment.
Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Bayer
◍ KPC Group
◍ Shanghai Pharma
◍ Rising Pharmaceutical
◍ CSPC Group
◍ Sun Pharma
◍ Zhongsheng Pharma
◍ Guangzhou Baiyunshan Guanghua Pharmaceutical
◍ Sichuan Sunny Hope
◍ Jinghua Pharmaceutical Group
◍ North China Pharmaceutical Group
The Chloroquine drug market for COVID-19 involves several key players, including Bayer, KPC Group, and Sun Pharma, which produce and distribute chloroquine for potential COVID-19 treatment. These companies contribute to market growth through R&D, manufacturing, and global distribution. Sales data includes:
- Bayer: Revenue $50 billion (2021)
- Sun Pharma: Revenue $4.5 billion (2021)
Request Sample Report
Market Segmentation
By Application
Mild Symptom Patient
Critically Ill Patient
Request Sample Report
By Product
Tablet
Injection
Market Growth
Request Sample Report
$ X Billion USD
